# Prostate cancer screening 2026: what the new ACS PSA guidelines say for men > The American Cancer Society now recommends routine PSA blood tests for many men aged 50 to 69. Who should screen, how often, what counts as high, and what to ask. Published 2026-11-12 · Updated 2026-11-12 · revns editorial On **12 November 2026** the **American Cancer Society (ACS)** published a new guideline for prostate cancer early detection. For the first time since 2010 it recommends **scheduled [PSA](/dictionary/prostate-specific-antigen) blood tests** for many asymptomatic men, not only optional tests after a one-to-one talk. **Average-risk men aged 50 to 69** should have a PSA test **every two years**. **Black men** and many men with a **close family history** should start at **age 45**, often **every year through 69**. That is a practical change for millions of men who train, work and see a primary care doctor for blood work anyway. **TL;DR** | Who | ACS 2026 screening | | --- | --- | | Average risk, ages 50–69 | PSA every **2 years** | | Black men, ages 45–69 | PSA **every year** | | Family history, ages 45–69 | **Yearly** if a father, brother or son had prostate cancer before 65, or more than one close relative; **every 2 years** if one relative was diagnosed at 65 or older | | Ages 70–74 | Shared decision; every 2 years if you choose to continue | | Ages 75+ | **Not recommended** (with narrow exceptions to discuss) | | Poor health, under 10 years life expectancy | **Not recommended** at any age | | PSA “high” | **≥ 3 ng/mL** if under 70; **≥ 6.5 ng/mL** if 70+; repeat in **2–12 weeks**, then MRI and/or biomarkers before many biopsies | ## Why did the American Cancer Society change its mind? Between 2010 and 2026, ACS told average-risk men to **choose** screening after learning benefits and harms, mirroring an era when many groups worried that PSA tests led to **overdiagnosis** and **overtreatment** of slow-growing cancers. New evidence, including updated reviews of screening trials, shifted the balance for some age groups toward **finding cancers earlier** and **lowering prostate-cancer deaths**, especially when follow-up uses **MRI** and **active surveillance** instead of immediate surgery for low-risk disease. The published guideline is *American Cancer Society guideline for the early detection of prostate cancer, 2026* (Hoffman et al., *CA: A Cancer Journal for Clinicians*). ACS also published a plain-language patient summary the same day. ## What exactly should men do under the new ACS schedule? The consumer summary on cancer.org spells out age bands: **Average risk.** Most men are not in a higher-risk category. From **50 through 69**, get a **PSA test every two years** once you have heard the benefits, limits and possible harms, what happens if PSA is high, and that **active surveillance** is the usual first step for many low-risk cancers. **Higher risk — Black men.** Begin at **45** with **yearly** PSA through **69**. Black men in the United States face **higher incidence and mortality** from prostate cancer; the guideline authors cite earlier and more aggressive presentation as one reason for earlier surveillance. **Higher risk — family history.** Non-Black men with prostate cancer in a **father, brother or son** also start at **45**: - **Every year** if a close relative was diagnosed **before 65**, or if **more than one** close relative had prostate cancer. - **Every 2 years** if only **one** close relative was affected and diagnosis was at **65 or older**. **Inherited risk.** Men with known high-risk gene changes (for example **BRCA2**) or untested relatives with such mutations should agree start age and interval with their clinician. **Ages 70–74.** Benefits and harms are **less clear**. Continue only if you and your clinician agree; if you screen, **every two years**. **75 and older.** ACS **does not recommend** routine screening. Very healthy men **75–79** with a **rising PSA trend** may discuss continuing; screening is **discouraged after 80** and when life expectancy is under **10 years**. ACS **does not recommend the digital rectal exam (DRE) as a screening test**, though it may still be used in work-up when PSA is abnormal. ## What PSA level counts as abnormal? Many US lab reports still flag PSA below **4.0 ng/mL** as “normal.” The **2026 ACS threshold is lower for younger men**: - **3 ng/mL or higher** if you are **younger than 70** - **6.5 ng/mL or higher** if you are **70 or older** If PSA is high, **repeat the blood test in about two to twelve weeks**. If it is still high, most men should have **prostate MRI and/or a biomarker blood or urine test** to refine biopsy decisions. Some men with very high PSA may go straight to biopsy; that is a clinical call. A high PSA does **not** always mean cancer. **Benign prostate enlargement**, **prostatitis** and recent **ejaculation or vigorous cycling** can raise PSA. That is why confirmation and imaging matter. ## How does this compare with the USPSTF? The **US Preventive Services Task Force** has **not** yet published a new final recommendation. Its **2018** statement still says men **55 to 69** should decide **individually** with a clinician (grade **C**), and it **recommends against** screening men **70 and older** (grade **D**). The USPSTF website lists prostate cancer screening as **“update in progress.”** In practice you may hear **different advice** from ACS, your health system and insurers until USPSTF finishes its review. Bring a written summary of your risk (age, race/ethnicity, family history) and ask which guideline your clinician follows. **Outside the United States:** the UK **NHS** does **not** run a national prostate screening programme like breast or bowel screening. Men can **request a PSA test** after an informed discussion with a GP. Canadian and Australian policies also differ. This article focuses on the **ACS 2026 US guideline**; adapt questions to your local system. ## What is active surveillance, and why does it matter for active men? If screening finds **low-risk** prostate cancer, ACS expects **active surveillance** as the **first management option**: regular PSA, repeat biopsies and sometimes MRI, with treatment only if the cancer shows signs of growth. That matters for men who lift, run or cycle: immediate surgery or radiation can carry **urinary, sexual and bowel side effects**. Surveillance lets many men **keep training** while the tumour is watched. It is not “doing nothing”; it is structured follow-up. ## Where do fitness, sleep and weight fit in? **Screening does not replace healthy habits.** ACS’s separate **diet and physical activity guideline for cancer prevention** recommends staying active and eating a diet rich in vegetables, fruits and whole grains. For day-to-day training: - **Strength work** two or more days a week supports muscle and bone as you age; see [strength training for beginners](/blog/strength-training-for-beginners) if you are new. - **Sleep** and **protein** underpin recovery; see [how much sleep you need](/blog/how-much-sleep-do-you-need) and [how much protein per day](/blog/how-much-protein-per-day). - **Cardiorespiratory fitness** from [Zone 2 training](/blog/zone-2-training-explained) supports heart health, which remains a leading concern for men in mid-life. revns does **not** store PSA results, order tests or interpret labs. It helps you **log training, sleep, meals and recovery** so you see patterns next to your [weekly check-in habits](/features/ai-fitness-coach). Use clinical portals for lab history. ## What should you do this week? 1. **Check your age and risk band** against the table above. 2. If you are **45–69** and due for screening, **book a clinician visit** or ask at your next blood draw whether PSA is included. Many men already have venous blood taken annually; adding PSA may be a single line on the lab order. 3. **Write down family history**: who had prostate cancer and at what age. 4. Before the test, ask what **PSA threshold** your clinic uses for referral and what **follow-up** (repeat test, MRI) they prefer. 5. Keep **training and sleep** consistent; avoid a hard new leg day or long bike session right before PSA if your clinician asks you to, since exertion can sometimes affect results. ## When should you see a clinician urgently? Ask for **prompt assessment**, with or without a recent PSA, if you have: - **New difficulty starting or stopping urine flow**, weak stream, or inability to urinate - **Blood in urine or semen** - **Bone pain**, especially in the back or hips, with no injury - **Unexplained weight loss** or persistent pelvic pain **Red flags during biopsy or treatment planning** (fever after biopsy, heavy bleeding) need same-day or emergency care per local instructions. revns is **training guidance**, not a medical record. It does **not** diagnose cancer or recommend treatment. ## How often will guidelines change again? Prostate screening guidance has shifted **three times in fifteen years** as trial follow-up lengthened and imaging improved. Expect **USPSTF** and **insurance rules** to update after their review. Save your **PSA dates and values** (from your patient portal) so you can see trends even when advice changes. ## What questions should you ask at your appointment? Useful prompts for a ten-minute visit: - **Am I average or higher risk** for prostate cancer given my age, race and family history? - **Does this clinic follow ACS 2026, USPSTF 2018, or another policy** for PSA intervals? - **What PSA number triggers a repeat test** here, and how soon should I retest? - **If PSA stays high, do you order MRI before biopsy**, and is active surveillance offered for low-risk results? - **Will my insurer cover PSA** on this schedule while USPSTF review is pending? Write the answers in your health app or a note on your phone. revns is for training logs, not clinical records, but keeping screening dates beside your sleep and load data helps you notice when life stress or travel might have affected a blood draw. ## Related - [Strength training for beginners](/blog/strength-training-for-beginners) - [Zone 2 training explained](/blog/zone-2-training-explained) - [How much sleep do you need?](/blog/how-much-sleep-do-you-need) - [AI fitness coach and week planner](/features/ai-fitness-coach) - [BMI calculator](/tools/bmi-calculator) This is general training and health literacy guidance, not medical advice. Screening and treatment decisions belong with a qualified clinician who knows your history. ## Sources - [Hoffman RM, Wolf AMD, Etzioni R, et al. American Cancer Society guideline for the early detection of prostate cancer, 2026. CA Cancer J Clin 2026](https://doi.org/10.3322/caac.70112) - [American Cancer Society. Guideline for prostate cancer early detection (patient summary, revised 12 Nov 2026)](https://www.cancer.org/cancer/types/prostate-cancer/detection-diagnosis-staging/acs-recommendations.html) - [US Preventive Services Task Force. Prostate cancer: screening (2018 recommendation; update in progress)](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening) - [Merelli A. American Cancer Society revises guidelines, urges routine PSA screening. STAT 12 Nov 2026](https://www.statnews.com/2026/11/12/prostate-cancer-screening-guidelines-updated-acs/) ## Questions ### What did the American Cancer Society change in 2026? ACS now recommends scheduled PSA blood tests for many men who previously only had shared decision-making at an annual check-up. Average-risk men aged 50 to 69 should be screened every two years. Higher-risk groups start earlier and may test yearly through 69. ### At what age should a man get his first PSA test under the new ACS guideline? Age 50 for most men at average risk, age 45 for Black men and for non-Black men with a close family history of prostate cancer, with yearly testing in some family-history patterns. After 70 the balance of benefit and harm is less clear and screening is individualized. ### What PSA level is considered high in the 2026 ACS guideline? A PSA of 3 ng/mL or higher is high for men younger than 70. For men 70 and older the threshold is 6.5 ng/mL or higher. A single high result should be rechecked after about two to twelve weeks before further work-up. ### Does the US government still recommend routine PSA screening for everyone? Not yet. The US Preventive Services Task Force 2018 statement still centres on individualized decisions for men 55 to 69 and recommends against routine screening from 70, and notes an update is in progress. Insurance coverage in the US often follows USPSTF grade A and B services. ### Does exercise replace prostate cancer screening? No. Regular strength training and aerobic activity support heart health, bone density and metabolic health, but they do not detect prostate cancer. Screening is a separate conversation with a clinician if you are in an age or risk group where PSA testing is offered. ### What symptoms need urgent medical review regardless of PSA results? New difficulty urinating, blood in urine or semen, unexplained bone pain, unexplained weight loss or severe pelvic pain should be assessed promptly. A normal PSA does not rule out every prostate problem. --- Canonical: https://revns.com/blog/acs-prostate-psa-screening-guidelines-2026 Index of everything: https://revns.com/llms.txt revns gives training guidance, not medical advice.